# OnCo record etomoxir (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/etomoxir/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "etomoxir" ;
  schema:name "Etomoxir"@en ;
  schema:description "Etomoxir is an older drug, first tested for heart failure, that Numiera Therapeutics is developing to starve glioblastoma cells of the fats they burn for energy. It has an FDA orphan designation for malignant glioma."@en ;
  schema:url <https://onco.cc/drugs/etomoxir/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1044424>, <https://www.numiera.com/etomoxir> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "Oral small-molecule CPT1 inhibitor" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/metabolic-therapy/> ;
  onco:companies <https://onco.cc/companies/numiera-therapeutics/> .